Ventures
Game changing startups.
Investors
A network of capital.
Upcoming Programs
Overview of opportunities.
Mentorship Marketplace
Find mentors or become one.
Startup Academy
Online courses and learning materials.
Blog
Startup related news.
What is VC4A?
Our thesis and background.
Our Team
The VC4A team.
Consulting
VC4A for business.
Hosted Communities
Dedicated communities on VC4A.
FAQs
Frequently asked questions.
Digital health and data-driven solutions that address key TB & HIV problems
PATH is a US-headquartered non-profit organisation whose mission is to advance health equity through innovation and partnerships. In relation to the project titled “Optimising data systems and digital health in South Africa,” PATH, is collaborating with Mobile Applications Laboratory (mLab), a technology innovation and skills accelerator, to manage two digital health, HIV/Tuberculosis-related innovation grants.
The top 2 ailments in South Africa in terms of burden of disease are: HIV/AIDS: South Africa has the highest prevalence of HIV/AIDS in the world, and the disease remains a major public health challenge, and Tuberculosis (TB): TB is the leading cause of death in South Africa, and the country has one of the highest TB incidence rates in the world.
Less than half the estimated 328,000 people with TB in 2021 were successfully treated. The World Health Organisation estimates that 55,000 people died from TB in South Africa in 2021 and it remains a leading cause of death in South Africa. The high prevalence of HIV, and socio-economic risk factors such as poor nutrition, over-crowding, and poor health-seeking behaviour all contribute. South Africa also has one of the highest HIV prevalence rates globally, with approximately 20% of adults living with HIV in the country. Despite progress in reducing new HIV infections, the number of new infections remains substantial. TB remains a leading case of death among people living with HIV.
South Africa has made significant strides in increasing access to antiretroviral treatment (ART). The country has one of the largest ART programmes in the world, with more than 5.5m patients on ART. Patients are able to pick up their HIV treatment at public primary health care clinics or other pick-up points available through the Central Chronic Medicines Dispensing and Distribution (CCMDD) programme. The programme provides more convenient options for patients to pick up their medication thus improving access and reducing workload on staff at primary healthcare facilities. However, a high proportion of patients cycle in and out of care at multiple points, particularly in the first 6 months.
Despite these challenges, tremendous potential remains to grow and harness in-country technological and digital health expertise to innovatively solve for health obstacles in a sustainable and impactful manner.
Digital health and data-driven solutions that address the key problems listed below are being sought:
mLab is seeking proposals from emerging enterprises in the start-up phase, or enterprises whose proposed solutions are not older than 5 years, and that clearly address any of the problem statements outlined. The applicant must be a South African registered entity. Preference will be given to those solutions that are at an advanced development stage or close to market pilot/entry. However, novel early-stage solutions that have been clearly substantiated may also be considered. University teams are also encouraged to apply. Applicants must clearly articulate how the proposed solution will scale and achieve sustainability.
Two grant awards are available. The grant is geared towards enterprises that intend meeting one or more of the following milestones:
Demonstrate the feasibility of their solution in a real-world context
Conduct market validation or pilot their solution
Building a conceptual model, collect and develop a data-driven solution
Conduct market research or feasibility studies to demonstrate the socio-economic potential of their solutions.
The proposal must not be longer than 15 pages and must include the following sections:
The following documents must accompany your application:
Preference will be given to:
The project must be completed, and a final report submitted, by 25 June 2024.
Technical merit, novelty , feasibility, and potential for scale? 45%
Quality of the proposal (clarity of goals, milestones and deliverables) 25%
Quality of the team and relevant expertise 20%
Transformation (youth, women, BBBEE rating) 10%
Two awards will be made to a maximum value of R1,2 million per grantee. This will be payable in tranches and against agreed milestones.
Queries can be emailed to: nicki@mlab.co.za